BioCardia, Inc. (BCDA) Tops Q3 EPS by 2c

BioCardia, Inc. (NASDAQ: BCDA) reported Q3 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $357 thousand versus the consensus estimate of $50 thousand.

For earnings history and earnings-related data on BioCardia, Inc. (BCDA) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Netskope, Inc. (NTSK) Tops Q1 EPS by 1c, Offers Guidance
• CrowdStrike posts record ARR growth, raises full-year outlook